CIM
GEVA

CenturyLink Investment Management’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

CenturyLink Investment Management’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,411
Closed -$235K – 316
2015
Q1 		$235K Buy
+2,411
New +$255K 0.08% 220

CenturyLink Investment Management's GEVA Position: Q2 2015 in Review

CenturyLink Investment Management sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 2,411 shares — an estimated $235K sold.

CenturyLink Investment Management first reported a position in GEVA in Q1 2015 and held it in 1 quarter. The position peaked at $235K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • CenturyLink Investment Management reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • CenturyLink Investment Management sold 2,411 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $235K.
  • CenturyLink Investment Management first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • CenturyLink Investment Management's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $235K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on CenturyLink Investment Management's 13F filing for Q2 2015, filed 10 Jul 2015.